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Abstract  
The main theme of this thesis research is concerned with developing a 
computational pipeline for processing Next-generation RNA sequencing (RNA-seq) data. 
RNA-seq experiments generate tens of millions of short reads for each DNA/RNA 
sample. The alignment of a large volume of short reads to a reference genome is a key 
step in NGS data analysis. Although storing alignment information in the Sequence 
Alignment/Map (SAM) or Binary SAM (BAM) format is now standard, biomedical 
researchers still have difficulty accessing useful information. In order to assist biomedical 
researchers to conveniently access essential information from NGS data files in 
SAM/BAM format, we have developed a Graphical User Interface (GUI) software tool 
named SAMMate to pipeline human transcriptome quantification. SAMMate allows 
researchers to easily process NGS data files in SAM/BAM format and is compatible with 
both single-end and paired-end sequencing technologies. It also allows researchers to 
accurately calculate gene expression abundance scores. 
Keywords 
Transcriptome 
Gene Expression 
Next-Generation Sequencing 
RNA-seq Pipeline 
SAMMate 
SAM/BAM Format 
Single-end/Paired-end
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Chapter 1. Background and Introduction  
1.1 Introduction to transcriptome  
The transcriptome is the set of all RNA molecules, including mRNA, rRNA, tRNA, and 
other non-coding RNA produced in one or a population of cells, or it can be referred to as the 
total of transcripts (or called isoform) or the specific subset of transcripts in a living cell. Unlike 
the genome that nearly does not change in a living cell except for mutation cases, the 
transcriptome varies according to different external environmental conditions, such as 
specialized tissues or cell lines. Most of the transcripts are processed by splicing to remove 
introns and generate a mature transcript or messenger RNA (mRNA) that only contains exons. 
Transcriptome is highly diverse, dynamic, complex and overlapping. Importantly, the range of 
transcriptome is enhanced by alternative splicing. Alternative splicing is a fundamental 
molecular process of multiple transcripts from a single gene due to variations in the splicing 
reaction of pre-mRNA. An exon can be either included or excluded from the mature transcripts. 
Thus, different splicing variants are generated from the same gene.  
1.2 Gene expression 
Gene expression is the synthesis process of a functional gene product by using the genetic 
information from a gene. These functional gene products include proteins and functional RNAs, 
the latter are in non-protein coding genes such as ribosomal RNA (rRNA) genes or transfer RNA 
(tRNA) genes. There are two major stages in gene expression. The first stage is transcription. In 
this stage, a single RNA molecule (a primary transcript) with basically the same sequence as the 
gene is produced. Most human genes consist of exons and introns, but only the exons carry 
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information required for protein synthesis. Therefore, most mature primary transcripts or 
mRNAs only contain exons by splicing to remove intron regions. The second stage is translation. 
In this stage, mRNA along with transfer RNA (tRNA) and ribosomes work together to produce 
proteins. Other stages of gene expression include RNA splicing and post-translational 
modification of a protein, and any step of gene expression may be modulated. In genetics, gene 
expression fundamentally interprets the genetic code stored in DNA.  
1.3 Microarray technology 
Microarray technology is referred to as a multiplex lab-on-a-chip technology that is 
widely used in molecular biology. A small solid glass slide or silicon thin-film cell attaches a 
large amount of different nucleic acid probes to hybridize a cDNA or cRNA sample (called 
target) under high-stringency conditions. The relative abundance of nucleic acid sequences in the 
target can be usually determined by detection and quantification of the probe-target hybridization. 
Microarray technology was once as the experiment of choice for transcriptome analysis. 
Applications of microarray technology widely involve gene discovery, disease diagnosis, drug 
discovery, toxicological research and so on. In contrast to digital counts of transcript abundance 
produced by Next-Generation Sequencing (NGS), the fluorescent dye–based microarrays 
generate analogous signals from image intensity. Although the use of microarrays remains active 
in a number of research areas, the promising NGS is becoming the method of choice due to the 
intrinsic experimental limitations of microarrays.  
1.4 Next-generation sequencing 
For many years, the microarray-based analysis of transcriptomes plays critical roles in 
interrogating a large portion of genes expressed in a cell. Nevertheless, microarray technologies 
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have several intrinsic limitations, such as signal saturation, biasness of probe design and non-
specific hybridization. High-throughput sequencing technologies have overcome many 
limitations of microarray technologies. NGS technologies sample the mRNA with fewer biases 
and generate tens of millions of short fragments from a library of nucleotide sequences. 
Currently, a range of genetic analyses, including whole genome resequencing, gene expression 
analysis and small ribonucleic acid (RNA) analysis, were supported by NGS platforms. For 
example, using the Illumina (http://www.illumina.com/) Genome Analyzer platform, recent 
applications include sequencing mammalian transcriptomes [Mortazavi et al. 2008], ABI Solid 
Sequencing to profile stem cell transcriptomes [Cloonan et al. 2008] or Life Science's 454 
Sequencing to discover SNPs in maize [Barbazuk et al. 2007]. Even though technical differences 
or applications exist in each platform, the information gathered from each share similar principle. 
Compared with microarray technology, RNA-seq experiments also provide much higher 
resolution measurements of expression at comparable costs [Marioni et al. 2008]. 
The following sections will introduce a series of relevant methods and analyses of whole-
transcriptome sequencing data (RNA-seq). 
1.4.1 RNA-seq technology 
RNA-seq, also called "Whole Transcriptome Shotgun Sequencing" [Ryan et al. 2008] 
("WTSS") and dubbed "a revolutionary tool for transcriptomics" [Wang et al. 2009], refers to the 
use of high-throughput sequencing technologies to sequence cDNA in order to get information 
about a sample's RNA content. RNA-seq quickly becomes invaluable in the study of diseases 
like cancer [Maher et al. 2009]. For many years, the standard method for determining the 
sequence of transcribed genes has been to capture and sequence messenger RNA using expressed 
sequence tags (ESTs) [Adams et al. 1993] or full-length complementary DNA (cDNA) 
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sequences using conventional Sanger sequencing technology. However, RNA-seq has a number 
of advantages over the conventional EST sequencing. RNA-seq samples the mRNA with fewer 
biases and generates tens of millions of short reads per experiment, and these data can be used in 
measurement of the level of gene expression.    
As an emerging RNA-seq technology, we are facing the challenge of complex alignment 
problem. In an RNA-seq experiment, the computing power to track all the possible alignments is 
nontrivial when aligning tens of millions of short reads to the reference genome. Besides, 
millions of reads unable to accurately align to the references genome when the reads originating 
from exon-exon junctions. Aligning reads originating from exon-exon junctions to references 
genome is also a hard nut to crack for researchers. Thanks to the deep coverage and base level 
resolution provided by next-generation sequencing instruments, RNA-seq provides researchers 
with efficient ways to interrogate transcriptome [Maher CA et al. 2009]. 
1.4.2 Short reads alignment 
In a typical RNA-seq experiment, tens of millions of short reads are generated from a 
library of nucleotide sequences. We need to map these short reads of mRNA to identify regions 
of similarity on a reference genome. Since these short reads are sequenced from exonic and 
junction regions, we need to pay attention to short reads aligned to those regions. Due to the 
short read length, aligning a large volume of short reads to a long reference genome poses a great 
challenge to analysis of RNA-seq data. For measuring gene expression, we often have to align 
short reads to original positions on a reference genome using alignment tools. There are several 
tools Maq [Li H et al. 2008] , SOAP [Li R et al. 2008], RMAP [Smith et al. 2008], Bowtie [Ben 
et al. 2009] and Novoalign (http://www.novocraft.com) available for aligning genomic reads to a 
reference genome.  
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1.4.3 Junction mapping 
Regarding alignment of short reads, a special attention is needed when processing the 
alignment of the short reads on both sides of the exon-exon junctions. Although most of the short 
reads can be mapped onto exon regions, a large set of short reads originating from exon-exon 
junctions still cannot be aligned against to reference genome. Thus, working with the short reads 
originating from exon-exon junctions in cDNA (around 10%) is a unique challenge for 
researchers. These short reads fail to map to the reference genome since the exons are separated 
by introns (Figure 1.1). Millions of unmapped short reads originating from exon-exon junctions, 
denoted as Initially Unmapped Reads (IUM's), need to be accounted for when measuring gene 
expression. To address the IUM problem, ERANGE [Mortazavi et al. 2008], Tophat [Trapnell et 
al. 2009] and rSeq [Jiang et al. 2008] are among the recently developed approaches to map 
IUM's originating from exon-exon junctions back to individual genes. ERANGE uses a union of 
known and novel junctions while Tophat de novo assembles IUM's using a module in Maq [Li H 
et al. 2008].  
 
Figure 1.1. Combination of exon reads with junction reads to accurately calculate gene 
expression RPKM scores. (a) A unique challenge for researchers working with RNA-seq data. 
The junction reads (red) fail to map back to the reference genome because exons are separated by 
introns. (b) A demonstration of the ideas of combing exon reads (black) and junction reads (red) 
to calculate gene expression RPKM scores. [Xu et al, 2011] 
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1.4.4 Data Format – SAM/BAM 
Sequence Alignment/Map (SAM) format is defined as a generic nucleotide alignment 
format which describes the alignment of query sequences or sequencing reads to a reference 
sequence or assembly [Li et al. 2009]. Many of these tools output the alignment results in the 
SAM and Binary SAM (BAM) formats [Li et al. 2009], which are widely considered the de facto 
standards for storing and transferring short read alignment results. Although SAM format is easy 
to understand and straight-forward, SAM is still a bit slow to parse. Therefore, Binary SAM 
(BAM) format is introduced for intensive data storing and parsing. SAM/BAM file can store 
both sing-end and paired-end reads. A mapped read pair is stored in two (or more if multiple hits 
are stored) separate alignment records [Li et al. 2009].  
SAM is a TAB-delimited text format. It generally consists of a header section and an 
alignment section. The header section is optional and it must be placed before the alignments 
section if present. Header lines start with ‘@’ and include format version, sorting order of 
alignments, related reference sequence dictionary and read group. In the alignments section, each 
alignment line has 11 mandatory fields for essential alignment information. For example, 
mapping position, and variable number of optional fields for flexible or aligner specific 
information (Figure 1.2). 
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Figure 1.2. Example of single-end reads in SAM format. 
In each alignment line, these mandatory fields are required to present in the same order, 
but their values can be ‘0’ or ‘*’ (depending on the field) if the corresponding information is not 
available. The following table gives an overview of the mandatory fields in the SAM format: 
Col Filed Type Regxp/Range Brief description 
1 QNAME String [!-?A-~] {1,255} Query template NAME 
2 FLAG Int [0,   -1] bitwise FLAG 
3 RNAME String \*|[!-()+-<>-~][!-~]* Reference sequence NAME 
4 POS Int [0,    -1] 1-based leftmost mapping POSition 
5 MAPQ Int [0,   -1] MAPping Quality 
6 CIGAR String \*|([0-9]+[MIDNSHPX=])+ CIGAR string 
7 RNEXT String \*|=|[!-()+-<>-~][!-~]* Ref. name of the mate/next fragment 
8 PNEXT Int [0,    -1] Position of the mate/next fragment 
9 TLEN Int [-   +1,    -1] observed Template LENgth 
10 SEQ String \*|[A-Za-z=.]+ fragment SEQuence 
11 QUAL String [!-~]+ ASCII of Phred-scaled base QUALity+33 
Table 1. 1 Overview of 11 mandatory fields in alignment line. 
[http://samtools.sourceforge.net/SAM1.pdf.] 
 
In each alignment line, all optional fields follow the TAG:TYPE:VALUE format where 
TAG is a two-character string that matches /[A-Za-z][A-Za-z0-9]/. Each TAG can only appear 
once in one alignment line. A TAG containing lowercase letters are reserved for end users. In an 
optional field, TYPE is a single case sensitive letter which defines the format of VALUE: 
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Type Regexp matching VALUE Description 
A [!-~] Printable character 
i [-+]?[0-9]+ Singed 32-bit integer 
f [-+]?[0-9]*\.?[0-9]+([eE][-+]?[0-9]+)? Single-precision floating number 
Z [ !-~]+ Printable string, including space 
H [0-9A-F]+ Byte array in the Hex format1 
B [cCsSiIf](,[-+]?[0-9]*\.?[0-9]+([eE][-+]?[0-9]+)?)+ Integer or numeric array 
Table 1. 2 Overview of optional fields in alignment line. 
[http://samtools.sourceforge.net/SAM1.pdf.] 
1.4.5 Quantification of gene expression using RNA-seq  
Quantifying gene expression in cells via measurement of mRNA levels arouses 
researchers’ interest all the time. In RNA-seq experiment, for each gene, ERANGE reports the 
number of mapped Reads Per Kilobase of exon per Million mapped reads (RPKM), a measure 
of transcription activity [Trapnell et al. 2009]. For paired-end short reads, we measure the 
transcript-level relative abundance in Fragments Per Kilobase of exon model per Million 
mapped fragments (FPKM).  
                
 
   
 
C is the total number of mapped short reads or fragments, L is the length of exons and N 
is the total number of short reads in one lane of one experiment. When scaled to range [0, 1000], 
this value stands for the normalized depth of coverage for each gene. Even though it has been 
shown that there is no strong correlation between the abundance of mRNA and the related 
proteins [Greenbaum et al. 2003], measurement of mRNA levels is still very useful in 
determining how cells differ between a healthy state and a diseased state and other research 
problems. 
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1.5 Motivation 
Intrinsic technical limitations to microarray technology constrain its ability to fully 
quantify gene expression. Fortunately, high-throughput multiplexed next-generation sequencing 
provides a digital readout of absolute transcript levels and imparts a higher level of accuracy and 
dynamic range than microarray platforms. In a typical experiment, tens of millions of short reads 
are sampled from RNA with fewer biases for accurately measuring gene expression. However, a 
significant challenge in analyzing gene expression is the short read alignment to a reference 
genome. Although storing alignment information in the Sequence Alignment/Map (SAM) or 
Binary SAM (BAM) format is a generic alignment format, biomedical researchers are still 
facing a technical obstacle in accessing the useful information stored SAM/BAM files. In this 
thesis, we present a GUI computational pipeline for researchers to efficiently process and extract 
information from NGS data for quantifying human transcriptome. We show our GUI software 
can accurately calculate the gene expression abundance scores for genomic intervals using short 
reads originating from both exons and exon-exon junctions for RNA-seq data.  
1.6 Overview 
This thesis is organized into 5 chapters. In Chapter 1 we introduce background, 
motivation and overview. In Chapter 2 we describe transcriptome and targetome analysis in 
MIR155 expressing cells using RNA-seq. In Chapter 3 we present RNA-seq Analysis of EBV 
Transcriptome. In Chapter 4 we discuss a GUI tool for processing short read alignments in 
SAM/BAM format named SAMMate. In Chapter 5 we draw a conclusion of the thesis and 
future efforts. 
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The thesis is largely based on the following list of relevant publications and software, 
 Transcriptome and targetome analysis using RNA-seq 
Xu, G, Fewell, C, Taylor, C, Deng, N, Hedges, D, Wang, X, Zhang, K, Lacey, M, Zhang, H, Yin, 
Q, Cameron, J, Zheng, L, *Zhu, D and *Flemington, EK: Transcriptome and targetome analysis in 
mir155 expressing cells using rna-seq. RNA (New York, N.Y.), 16(8):1610–1622, August 2010. 
 
#Lin, Z, #Xu, G, Deng, N, Taylor, C, *Zhu, D and *Flemington, EK: Analysis of EBV 
transcriptome using RNA-seq. J. Virology, doi:10.1128/JVI.01521-10. 
 
 SAMMate: a GUI tool for processing short read alignments in SAM/BAM format  
Xu,G, Deng, N, Zhao, Z, Zhang, K, Judeh, T, Flemington, EK and *Zhu, D: SAMMate: A GUI tool 
for processing short read alignment information in SAM/BAM format. Source Code for Biology 
and Medicine, 6:2. 
 
 Software 
SAMMate with Graphic User Interface (GUI) [available from, http://SAMMate.sourceforge.net] 
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Chapter 2. Transcriptome and Targetome Analysis in MIR155 
Expressing Cells using RNA-seq 
2.1 Introduction   
      MicroRNAs play critical roles in controlling biological processes through their ability to 
post-transcriptionally regulate gene expression. A testament to their importance in normal 
organismal biology is that dysregulation of microRNA function through genetic or epigenetic 
alterations is at the root of an array of disparate diseases including cancer [Calinet al. 2004; Iorio 
et al. 2005; Lu et al. 2005; Volinia et al. 2006; Zhang et al. 2006]. The gene encoding 
microRNA-155(MIR155) was classified as an oncogene [Clurman and Hayward 1989; Tam et al. 
1997; Costinean et al. 2006] many years before it was identified as a microRNA [Eiset al. 2005] 
and is now among the most highly implicated microRNAs in cancer. Despite its link to 
hematologic [Eiset al. 2005; Kluiver et al. 2005] and other cancers [Volinia et al. 2006], there is 
currently little information regarding direct targets or pathways through which MIR155 signals 
to promote the tumor phenotype. 
The phenotypic consequences of microRNAs are facilitated through the combination of 
not only direct, but also indirect, influences on gene expression. Nevertheless, the identification 
of direct target mRNAs is a topic of intense interest because it provides insights into the entry 
point through which microRNAs regulates a respective pathway. The recognition of targets 
through a predominantly Watson–Crick base-pairing mechanism has capacitated informatics 
based prediction approaches that have lent considerable support to global target identification 
efforts [Li et al. 2010b]. Despite the applicability of this approach, there are less tangible 
flanking sequence criteria that also play a role in specifying targeting [Hammell 2010]. This 
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limits the veracity of informatics-based target prediction and necessitates the concomitant 
application of experimental methods to search for and/or validate microRNA targets. High-
throughput sequencing of RNAs isolated by cross-linking immunoprecipitation (HITS-CLIP) is a 
recently developed method that enables identification of direct target sequences through the 
sequencing of RNAs from immunoprecipitated cross-linked Argonaute–miRNA–mRNA 
complexes [Chi et al. 2009]. The use of SILAC (stable isotope labeling with amino acids in cell 
culture) and state-of-the-art mass spectroscopy approaches has allowed the interrogation of up to 
5000 members of a proteome for changes in protein output in response to micro-RNA expression 
[Selbach et al. 2008]. Whereas HITS-CLIP can directly identify targeting sequences, proteomics 
approaches identify an inferred targetome. On the other hand, SILAC-based proteomics 
approaches also provide expression information for directly and indirectly affected genes that 
can give additional insights (relative to HITS-CLIP) into the biological outcomes of a 
microRNA’s function. In spite of this, proteomics methods likely miss up to half of all expressed 
proteins and may be biased against the less abundant proteins that often play critical regulatory 
roles in cell signaling. 
Microarray-based analysis of transcriptomes has the potential to interrogate a much larger 
portion of all genes expressed in a cell, and this approach has been used to globally characterize 
microRNA-mediated transcriptome changes and inferred targetomes (for example, see Grimson 
et al. 2007). Nevertheless, microarray technologies have several intrinsic characteristics that limit 
their utility in fully exploiting RNA changes to assess microRNA-induced transcriptome changes 
and microRNA targetomes. High-throughput sequencing of RNAs has overcome many of these 
limitations, and we reasoned that next-generation sequencing (NGS) may provide an 
improvement over microarray technologies. The higher level of accuracy of NGS [Marioni et al. 
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2008; Mortazavi et al. 2008] should make it more suitable for assessing the relatively moderate 
influences that microRNAs have on their target mRNAs. Its broader dynamic range allows the 
analysis of both high- and low-abundance transcripts and should therefore facilitate the analysis 
of genes spanning a wide spectrum of expression levels. Unlike the most commonly used 
microarray platforms, which only interrogate the ends of terminal exons to derive expression 
information, NGS gathers expression information throughout the entire locus of all expressed 
genes. This feature of NGS is important in light of recent studies showing the occurrence of 
widespread upstream transcription termination shifts during immune cell development and in 
cancer cells, for example, Sandberg et al. (2008) and Mayr and Bartel (2009). For genes 
simultaneously expressing shortened and long transcripts, expression changes obtained by 
microarray studies reflect only changes in the subset of extended isoforms that may be more 
responsive to microRNA targeting but do not accurately mirror overall changes in expression of 
the locus. Finally, NGS allows the user to simultaneously assess isoform structure, which is 
critically important for many regulatory processes including microRNA targeting. This 
information can be used to elucidate targeting failures in a particular system. We also anticipate 
that as the potential targetomes of microRNAs become well characterized and as NGS data 
become broadly accumulated for different cell systems, actual targetomes can be predicted for 
each cell system based on transcript structure. This should allow for informed prediction of 
biological outputs of microRNAs in different cell systems based on publicly available 
information alone. 
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2.2 Results 
2.2.1 Model system  
     Epstein-Barr virus (EBV) infected B-cells expressing the full repertoire of latency genes 
(type III latency) manifest high levels of MIR155, whereas EBV-infected B-cells exhibiting a 
limited viral gene expression program (type I latency) do not [Jiang et al. 2006; Kluiver et al. 
2006]. To investigate the utility of next generation RNA sequencing (RNA-seq) in assessing a 
microRNA targetome, we infected the type I latency B-cell line, Mutu I, in duplicate with an 
MIR155 expressing retrovirus (or an empty vector control etrovirus) to achieve high MIR155 
expression in a low expression background. Infections were judged to be highly efficient based 
on the low level of cell death after selection and the high percentage of GFP-positive cells (>60%) 
2 d after infection. We therefore considered the infected cell populations to be highly polyclonal. 
Expression of MIR155 was found to be  100, 000-fold higher in MIR155 transduced Mutu I 
cells than in control transduced Mutu I cells or in two other type I latency cell lines (Figure 2.1A, 
Akata and Rael). Additionally, expression in MIR155 transduced Mutu I cells was comparable to 
endogenous MIR155 expression in the type III latency cell lines, JY, X50-7, and IB4 (Figure 
2.1A). The level of MIR155 in retrovirally transduced Mutu I cells was found to be sufficient to 
exert suppression of the previously identified MIR155 target, BACH1 [Figure 2.1B; Gottwein et 
al. 2007; Skalsky et al. 2007; Yin et al. 2008]. Furthermore, ectopic MIR155 exerted a 
phenotypic influence on Mutu I cells since MIR155 transduced cells formed more colonies in 
soft agar than their control transduced counterparts (Figure 2.1C), a result that is consistent with 
the known oncogenic properties of MIR155. We therefore considered this system to be suitable 
for carrying out MIR155 transcriptome and targetome analysis using RNA-seq. 
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Figure 2.1 The biological system. (A) Mature MIR155 was analyzed by real-time RT-PCR in the 
EBV type I latency cell lines—Akata, Rael, and Mutu I—and the type III latency cell lines—JY, 
X50-7, and IB4. CNTL-1 and CNTL-2 and 155-1 and 155-2 refer to duplicate biological 
replicate infections with control and MIR155 expressing retroviruses. Expression values are 
reported relative to the average expression levels in Akata and Rael. (B) BACH1 and ACTB (b-
actin) Western blots were performed using protein extracts isolated 14 d after retroviral 
infections. (C) Newly established control and MIR155 expressing Mutu I cells were plated in 
soft agar and cultured for 2 wk prior to photo-documentation. (D) The total number of genes and 
the number of genes containing any MIR155 seed type that are expressed above and below the 
indicated RPKM cutoffs in control Mutu I cells were counted and graphed. 
 
2.2.2 Read mapping 
Control and MIR155 transduced Mutu I RNAs were analyzed by NGS using an Illumina 
Genome Analyzer II. Reads per kilobase of exon model per million mapped reads (RPKM) 
[Mortazavi et al. 2008] was used to score gene expression abundance. A unique challenge for 
working with RNA-seq data is short reads originating from exon–exon junctions in cDNAs 
( 10%) that fail to map back to the reference genome because in this context, exons are 
separated by introns. The millions of unmapped short reads originating from exon–exon 
junctions, denoted as initially unmapped reads (IUMs), needed to be accounted for when 
calculating RPKM scores [Trapnell et al. 2009]. While most aligners (named ‘‘exon aligner’’ 
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hereinafter) map only short reads originating from exons (ignoring IUMs), ERANGE [Mortazavi 
et al. 2008], TopHat [Trapnell et al. 2009], and rSeq [Jiang and Wong 2008] (named ‘‘junction 
mapper’’ hereinafter) are among recently developed approaches to assign IUMs originating from 
exon–exon junctions back to individual genes.  
The exon aligners and junction mappers differ vastly in algorithms and accuracy. For 
RNA-seq data, it is necessary to choose and combine the most accurate exon aligner and junction 
mapper to estimate the gene expression RPKM scores. In our analysis, alignments were first 
carried out using the exon aligner Novoalign (http://www.novocraft.com), with reads aligning to 
more than one locus excluded from further analysis. IUMs were secondly de novo aligned to the 
assembled IUMs using the junction mapper TopHat [Trapnell et al. 2009]. IUMs mapping to 
exon junctions using TopHat were then combined with exon mapped reads from the Novoalign 
output, and RPKM calculations were carried out using University of California Santa Cruz 
(UCSC)–annotated gene loci [Rhead et al.2010]. 
2.2.2 Expression analysis 
Microarray technologies can readily be used to generate information regarding the 
relative expression of genes between samples. Due in part to cross-hybridization and sensitivity 
issues as well as the analog nature of microarray platforms, however, the determination of 
absolute transcript levels is challenging. In contrast, NGS provides a digital readout of the 
number of reads mapping to each gene, and Li et al. (2010a) have shown that when the mean 
expressed transcript length is 1 kb, 1 RPKM corresponds to roughly one transcript per cell in 
mouse. It is reasonable to assume that transcript levels falling below this threshold may be of 
limited functional significance to the overall cell population. At the very fundamental level of 
RPKM analysis, NGS allows the user to tentatively absolve this group of genes from playing a 
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direct global role in altering cell signaling/phenotype in a particular system. Such genes can be 
set aside and perhaps considered at a later point in the context of paracrine or subpopulation 
effects. In control Mutu I cells, approximately half of all annotated genes were found to be 
expressed below 1 RPKM (Figure 2.1D). Approximately 800 genes bearing MIR155 3’ UTR 
seed sequences were found to be expressed below 1 RPKM. Even at a 0.1-RPKM cutoff, more 
than 600 seed containing genes were found to fall below this threshold and are therefore likely to 
have limited functional significance in these cells irrespective of whether they are true MIR155 
targets. Notably, a higher percentage of MIR155 seed containing genes are expressed in Mutu I 
B-cells compared to the percentage of all genes expressed, possibly reflecting the critical role of 
MIR155 in immune cell development [O’Connell et al. 2007; Rodriguez et al. 2007]. 
Alternatively, this enrichment may simply reflect a general bias toward targeting a group of 
genes that are universally expressed. 
2.2.3 Relative expression and distribution of genes with 3’ UTR 
MIR155 seed sequences 
We next assessed whether genes containing MIR155 3’ UTR seed sequences are 
preferentially distributed among down-regulated genes. Genes expressed below 0.5 RPKMs were 
excluded from this analysis since these genes are likely of arguable functional significance and 
technical reproducibility begins to wane in this RPKM range [Mortazavi et al.2008]. In line with 
expectations, we observed preferential distribution of genes containing 7-mer and 8-mer MIR155 
seed sequences in the down-regulated fractions (Figure 2.2A–C). Statistical analysis 
demonstrated preferential distribution (P-value <          ) in terms of mean and variance (for 
details, refer to the Materials and Methods section). Cumulative distribution plots showed 
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enrichment of all classes of 7-mers and 8-mers in the down-regulated fractions relative to genes 
with no 7-mer or 8-mer seeds (P-value <          ) (Figure 2.2D). Notably, even among genes 
without MIR155 seed sequences, there is a greater number of down-regulated compared to 
induced genes, indicating a more global redistribution of gene expression. This is not 
inconsistent with previous microarray studies showing that MIR155 down-regulates more genes 
than it induces [Gottwein et al. 2007; Skalsky et al. 2007]. Because RPKM calculations 
normalize to all mappable reads, these results presumably mean that MIR155 decreases the 
expression of genes within the lower expression class through a mechanism other than 3’ UTR 7-
mer or 8-mer basepairing. Irrespective of this issue, the enrichment for genes with 7-mer or 8-
mer seeds in the down-regulated fractions relative to genes without 7-mer or 8-mer seeds is 
consistent with expectations based on previous microarray studies. As further evidence that 
RNA-seq analysis performed within expectations, we observed a down regulation bias for genes 
containing 3’ UTRs with greater numbers of 7-mer or 8-mer seeds (Figure 2.2E). 
19 
 
 
Figure 2.2. Genes containing MIR155 seed sequences are enriched in down-regulated fractions. 
Relative expression (expression in MIR155 transduced Mutu I cells divided by the expression in 
control transduced Mutu I cells) histograms for genes containing 7-mer or 8-mer (A), 8-mer (B), 
or 7-mer (C) seeds in their 3’ UTR. (D) Cumulative distribution of genes with different seed 
classes. P-values for all seed classes as determined by one-sided Wilcoxon test (Wil.) and one-
sided Kologorov–Smirnov test (K-S) were <        . (E) Cumulative distribution of genes 
with different numbers of seeds. P-values for all seed number comparisons were determined 
using a one-sided Wilcoxon test and a onesided Kologorov–Smirnov test and are shown in the 
matrix to the right. 
 
2.2.4 NGS versus microarray studies 
Having demonstrated a preferential distribution of genes with MIR155 seeds in down-
regulated fractions, we next sought to assess the performance of next generation sequencing 
relative to microarray analysis. We performed differential expression analysis on our RNA-seq 
data set and on data sets from two previously published microarray studies in which MIR155 
expression vectors were introduced into either a mouse macrophage cell line [O’Connell et al. 
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2008] or human 293 cells [Skalsky et al. 2007]. Using only gene identifiers common to all four 
platforms and using a false discovery rate (FDR) of zero, 2165 genes were determined to be 
down-regulated by NGS, whereas 38 and 58 down-regulated genes were identified in our 
analysis of the two published microarray data sets (Figure 2.3). NGS identified 102 down-
regulated genes (FDR = 0) with 3’ UTR 8-mer seeds, while seven and two down-regulated genes 
with 8-mer seeds were identified in the two microarray data sets.  
To more stringently assess the relative robustness of NGS for transcriptome and 
targetome studies, we generated additional control and MIR155 retrovirally transduced Mutu I 
cell lines and subjected four control and four MIR155 expressing cell lines to Agilent microarray 
analysis with dye swaps for each comparison. This resulted in better concordance relative to 
previous microarray studies, but the number of downregulated genes and the number of down-
regulated genes with 8-mer seed sequences were threefold and 2.6-fold lower than that observed 
using the NGS data set (Figure 2.3). 
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Figure 2.3. Cross-platform comparison of transcriptome quantification using bitmap. 
Downregulated genes were identified at a false discovery rate (FDR) = 0 for NGS and each 
microarray platform. Each gene was determined to be significantly down-regulated (at FDR = 0) 
or not in each of the four platforms; down-regulated genes were assigned to one of the    = 16 
possible clusters, represented by color/white patterns and corresponding to 16 rows in the bitmap. 
Numbers at the top refer to the total number of down-regulated genes for the indicated platform 
(summation of the number of genes represented by all colored patterns in column). Numbers to 
the right refer to the number of genes common to platforms with colored patterns in each 
respective row. 
 
2.2.5 3’ UTR reporter analysis 
Luciferase reporter plasmids bearing ectopic 3’ UTRs can be used to assess microRNA 
targeting through the respective 3’ UTR. To further analyze the inferred targetome derived from 
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NGS, a 3’ UTR reporter data set was generated using 170 3’ UTRs containing MIR155 7-mer or 
8-mer seeds and nine 3’ UTRs with no MIR155 seeds (Figure 2.4A). The relative expression of 
reporters lacking MIR155 seeds in cells cotransfected with a MIR155 expression vector versus a 
control expression vector fell in the range of 0.8 to 1.04. The relative expression of genes with 
MIR155 seed sequences spanned a range from 0.13 to 1.2 (Figure 2.4A; Supplemental Data 1), 
allowing us to analyze a spectrum of MIR155 target regulatory classes. 
 
Figure 2.4. Validation of RNA-seq analysis using 3’ UTR assay. (A) Distribution of 3’ UTR 
suppression by MIR155 in reporter assays. Detailed information including gene names for each 
data point is presented in Supplemental Data 1. Genomic coordinates for each 3’ UTR in reporter 
constructs are listed in Supplemental Data 4. Values are the expression of reporters in cells 
cotransfected with the MIR155 expression vector versus cells cotransfected with the control 
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expression vector divided by the expression of the control reporter cotransfected with the 
MIR155 expression vector versus cells cotransfected with the control expression vector. Results 
are based on biological triplicate transfections with control and MIR155 expression vectors. 
Error bars are standard error of change. (B) Comparison of relative expression observed in 3’ 
UTR assays with relative expression of endogenous transcripts at the whole locus level. The y-
axis values are the relative expression observed in 3’ UTR assays divided by the relative 
expression of the endogenous transcripts (at the whole locus [W.L.] level). Genes with yellow 
shading are genes considered to lack full response at the endogenous transcript level. Genes with 
green shading fall within the expected difference range. Genes with pink shading represent 
candidate genes whose transcripts are regulated through additional mechanisms in Mutu I cells. 
The arrow indicates an inflection point in the curve. 
 
2.2.5 Validation of RNA-seq analysis using 3’UTR luciferase reporter 
assay 
A total of 150 of the 170 genes tested in the 3’ UTR reporter study were expressed at 0.5 
or more RPKMs in Mutu I cells, allowing us to do comparisons with these 150 genes. Whereas 
changes observed by RNA-seq only reflect influences at the transcript level, changes observed in 
3’ UTR assays reflect the combined influence of transcript level changes plus the influence of a 
microRNA on translation, the latter of which is expected to vary depending on the target. In line 
with expectations, the majority (76%) of genes tested showed greater than or equal suppression 
in 3’ UTR reporter assays relative to the RNA-seq analysis (Figure 2.4B; Supplemental Data 2). 
Of the remaining 24% of genes that displayed greater suppression as observed by RNA-seq 
versus 3’ UTR analysis (values >1 in the y-axis of Figure 2.4B), at least some of these genes are 
likely to be modulated endogenously through additional mechanisms such as transcriptional 
regulation (especially those to the right of the apparent inflection point; see arrow in Figure 
2.4B). 
Although the relative contribution of translational inhibition varies from target to target, 
it appears that decreases in protein levels are rarely more than twice the decrease in RNA levels 
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[Selbach et al. 2008]. In our case, there are 29 genes (19%) with more than twofold greater 
inhibition in 3’ UTR assays compared to the inhibition observed at the endogenous transcript 
level (Figure 2.4B; Supplemental Data 2). We operationally treated these genes as outliers that 
show a disproportionately lesser degree of regulation at the level of RNA-seq. 
To investigate these poor performers, we first directed our attention to some of the most 
extreme examples, those with little or no regulation observed by RNA-seq but good regulation in 
our 3’ UTR analysis. Three examples—PCDH9, MAP3K10, and TAF5L (Supplemental Data 
3)—proved to be illustrative of scenarios accounting for some of these targeting 
failures/inefficiencies. First, suppression of the PCDH9 3’ UTR in the reporter assay was found 
to be substantial (relative expression of 0.26), whereas there was no change in RNA-seq (relative 
expression of 1.0). Visualization of the read pile-ups on the USCS Genome Browser [Rhead et al. 
2010) showed no evidence of reads mapping to exons 3, 4, or 5, the latter of which contains the 
MIR155 seed sequence (Supplemental Figure 2.1). In contrast, ample read evidence supports 
transcription through exons 1 and 2, and splicing evidence supports an exon 1 and exon 2 
junction. In this example, PCDH9 is likely to be a true target of MIR155 as evidenced by the 3’ 
UTR reporter analysis. The lack of any change in PCDH9 transcript levels in Mutu I cells is 
likely an accurate reflection of the dominant utilization of an isoform that is recalcitrant to 
MIR155 targeting. 
Several recent studies have demonstrated 3’ UTR shortening in activated lymphocytes 
and in tumors [Sandberg et al. 2008; Mayr and Bartel 2009]. The lack of a change in MAP3K10 
transcript levels as determined by RNA-seq analysis in the face of a relative expression of 0.47 
observed by 3’ UTR analysis likely reflects such a scenario. In this case, read evidence falls off 
upstream from the MIR155 seed sequence, a localization with proximity to the end of a shorter 3’ 
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UTR isoform entry identified from the GenBank database (Z48615) (Supplemental Figure 2.2). 
MAP3K10 is a representative example of a lack of responsiveness resulting from the dominant 
usage of an upstream poly-adenylation site.  
Expression of MIR155 in Mutu I cells resulted in no observable change in overall TAF5L 
RNA levels despite the presence of a 3’ UTR with five MIR155 sites and a relative expression of 
0.3 observed in our 3’ UTR analysis. TAF5L has two annotated isoforms with two distinct 3’ 
UTRs (Figure 2.5A, B). In contrast to the 3’ UTR tested in our 3’ UTR analysis, the other 3’ 
UTRs contains no MIR155 seed sequences. Although both isoforms are expressed in Mutu I 
cells, RPKM analysis of exon 5 (no MIR155 seeds) and the unique region of exon 4 (5 MIR155 
seeds) shows that the relative abundance of the isoforms containing seeds is  20- fold lower 
than the isoforms lacking seeds (Figure 2.5C). This dominant expression of the non-seed-
containing isoform can explain the lack of observable changes in overall TAF5L transcripts in 
MIR155 expressing Mutu I cells. To determine whether the seed-containing isoform is regulated 
by MIR155 in Mutu I cells, we calculated the differential expression of 3’ UTR sequences that 
are unique to this transcript. Whereas the relative expression of exon 4 (common to both 
isoforms) and exon 5 are   , the relative expression of the unique region is 0.52 (Figure 2.5D), 
which is in line with the relative expression observed for this 3’ UTR in the reporter assay 
(Figure 2.5E). Therefore, while the dominance of the nonseed containing TAF5L isoform results 
in no change at the whole locus level, the seed containing isoform is specifically regulated by 
MIR155 in concordance with the 3’ UTR results. 
2.2.6 Global analysis of terminal exon relative expression 
We used these examples of targeting failures as a basis to design a general approach to 
assess the degree to which differential isoform usage contributes to mitigated suppression in 
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Mutu I cells. We reasoned that the relative expression of terminal exons would better reflect the 
degree of suppression observed in 3’ UTR assays in cases in which multiple transcript isoforms 
account for mitigated suppression in our cells (as observed by RNA-seq analysis of the whole 
transcript locus). First, for genes using more than one terminal exon, the terminal exons bearing 
MIR155 seed sequences should, on average, show a higher degree of suppression than the whole 
locus. Second, for genes bearing only one terminal exon but using more than one poly(A) signal, 
there should be a higher relative read representation of longer MIR155 seed containing 
transcripts within terminal exon coordinates compared to the whole gene locus.  
For this analysis, RPKM and corresponding relative expression calculations were carried 
out for all terminal exon loci.We first applied this terminal exon differential expression data to 
the group of genes (excluding PCDH9, MAP3K10, and TAF5L) showing a disproportionately 
greater suppression in the 3’ UTR assays relative to RNA-seq (3’ UTR relative expression/RNA-
seq [transcript] relative expression <0.5). Genes with terminal exon RPKM levels of <0.5 were 
excluded from this analysis. Of the 23 testable genes, better concordance with 3’ UTR data was 
achieved with the terminal exon analysis in a little more than half of the genes (Figure 2.6A). 
This indicates that, in these cases, the inability of MIR155 to suppress expression of these genes 
to its full potential is likely due to the expression of alternate nonsuppressible isoforms. 
At the global level, cumulative distribution analysis of terminal exons with or without 
MIR155 seed sequences shows a relative enrichment of seed containing genes in the down-
regulated fractions (P-value <         ) (Figure 2.6B), in line with the whole locus analysis 
shown in Figure 2.2. However, greater inhibition is observed at the terminal exon level than the 
whole locus level (Figure 2.6C), indicating that isoform usage likely dictates the degree of 
suppression for a broad spectrum of MIR155 targets. Together, these data support the contention 
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that for some targets, a lack of miRNA repression responses at the endogenous transcript level 
can be attributed to altered transcript structure. 
2.3 Discussion 
There are now a number of tangible methods to globally assess the influence of 
microRNAs on cell signaling, which range from an assessment of RNA binding sites (e.g., 
HITSCLIP), to an assessment of changes in RNA (e.g., microarray and NGS) and protein output 
(e.g., SILAC). Each of these methods has its own niche in determining the overall cascade of 
events leading to a microRNA’s influence on cell signaling pathways. A unique advantage of 
NGS is its capacity to simultaneously provide accurate transcript level information while, at the 
same time, providing unprecedented clarity regarding transcript structure at a relatively low cost. 
Our data support the contention that mRNA isoform utilization is a critical determinant in 
specifying microRNA targeting. It also advocates transcriptome and miRNA targetome 
characterization at the isoform level as opposed to the typically used gene level analysis. In our 
experiments, transcript structure information obtained by NGS provided clarity with respect to at 
least half of all targeting failures and/or inefficiencies (Figs. 2.5, 2.6; Supplemental Figs. 2.1, 
2.2). In addition, NGS provides the user with information on ‘‘failures to detect’’ changes that 
are attributed to low (or no) target gene expression (in our case, 39% of all genes with seed 
sequences were expressed below 0.5 RPKMs). NGS makes these transcriptome level targeting 
inefficiencies and/or failures transparent to the user. 
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Figure 2.5. Isoform-dependent regulation of TAF5L by MIR155. (A) Gene structures of 
annotated TAF5L transcripts. (B) Expanded depiction of genomic sequences spanning exons 4 
and 5 with accompanying read evidence. Splicing evidence indicates that reads spanning the 
exon 4/5 junction were found in control (CNTL-1) and MIR155 (155-2)–expressing cells. Pile-
ups are a representation of the number of reads identified at each nucleotide position. (C) 
Quantitative analysis of read coverage (RPKMs) across exon 5 and the unique 3’ UTR sequences 
containing MIR155 seed sequences. RPKM calculations were performed based on the number of 
reads in control Mutu I cells. (D) Relative expression of TAF5L whole locus (W.L.), TAF5L 
exons 4 and 5, and unique 3’ UTR containing MIR155 seed sequences were calculated based on 
RPKM calculations performed using the appropriate respective feature annotations. Error bars 
are standard error of change. (E) 3’ UTR assay showing suppression of 3’ UTR containing 
MIR155 seed sequences. These results are extracted from the data shown in Figure 2.4. 
29 
 
The accumulation of publically available RNA-seq data for different cell lines and 
different model systems willlikely accelerate rapidly in the near future. We also envision that 
microRNA targetomes will soon become much better elucidated. Using informatics alone, RNA 
structure information derived from publically available NGS sequencing databases could be 
merged with a well-characterized targetome data set to allow investigators to make predictions 
regarding the cell type–restricted targetome. This will facilitate a much better informed 
prediction of the functional impact of a microRNA in the context of a particular cell system. 
 
Figure 2.6. Mitigated response of endogenous genes to MIR155 is mediated in part by alternate 
transcript structure. (A) Comparison of relative expression at the whole locus level, the terminal 
exon level, and in 3’ UTR assays. The genes depicted are only those showing greater than 0.5 
RPKMs in whole locus sequencing and in the terminal exon analysis. Error bars are standard 
error of change. (B) Cumulative distribution plot of terminal exon analysis shows a highly 
significant relative expression shift for genes with MIR155 seeds versus genes without seeds. P-
values as determined by a one-sided Wilcoxon test (Wil.) and a one-sided Kologorov–Smirnov 
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test (K-S) were found to be <        . (C) Terminal exon analysis shows significantly more 
down-regulation than whole locus analysis implicating transcript structure in mitigating MIR155 
responses at the whole locus level. P-values were determined by a one-sided Wil. test and a one-
sided K-S test. 
 
Probes used for most nontiling microarrays are typically at or near the 39 end of terminal 
exons. Such probes exclusively interrogate longer isoforms that are expected on average, to be 
more susceptible to microRNA targeting. This may account for some of the down-regulated 
genes uniquely identified in the Agilent microarray platform relative to NGS (Figure 2.3). 
Despite the intrinsic bias that these microarrays have toward more regulatable isoforms, NGS 
identified 2.6 times more down-regulated genes with 8-mer seeds than our Agilent microarray 
data from the same cell system (FDR = 0) (Figure 2.3). NGS is therefore a more robust platform 
to identify an inferred targetome while providing a better reflection of overall gene expression 
since read frequency throughout the entire locus (or through the open reading frame [ORF]) can 
be considered. At the same time, NGS provides the flexibility to assess isoform-specific 
regulation by considering read frequency through isoformspecific exons or through isoform-
specific 3’ UTR sequences only.  
Identification of microRNA targets is critical for understanding the initial contact point 
between a microRNA and an affected pathway and biological function. Nevertheless, the overall 
biological impact of a microRNA is manifested by the combination of these direct interactions 
and downstream regulatory processes that are influenced by direct interactions. An illustration of 
this point was educed by Gene Ontology analysis (Ingenuity Pathway Analysis software; 
Ingenuity) of MIR155-regulated genes. The most highly implicated biological process predicted 
from a gene set containing either regulated genes with MIR155 seeds or any regulated gene was 
the cell cycle (which may contribute to the oncogenic function of MIR155) (Supplemental 
Figure 2.3). Despite this consistency, there are a far greater number of genes implicated in this 
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process from the latter case (total of 92 genes) than the number of regulated genes with seeds 
(total of 10 genes). Many of these additional genes are likely regulated through downstream 
regulatory processes, yet they presumably have a contributing impact on this biological process.  
To our knowledge, there is no reason to expect that indirect effects of microRNA 
targeting would be restricted to nontargets. The addition of an indirect component to direct 
targets could serve to either reinforce down-regulation, thereby exerting a stronger impact on a 
pathway, or provide a negative feedback loop to transiently influence a pathway. Both scenarios 
may explain discordant 3’ UTR reporter/NGS data that cannot be explained by altered transcript 
structure. KLRA1 and HAL (this study), and SMAD1 and MYO10 (see below) [Yin et al. 2010; 
this study], are examples of genes showing relative expression of 0.6 or less in 3’ UTR assays 
but whose relative expression at the endogenous RNA level was found to be  50% of their 3’ 
UTR relative expression levels. These genes appear to be true targets of MIR155, but the greater 
observed regulation at the transcript level suggests a reinforcing component to the regulation of 
these genes.  
Based in part on the RNA-seq data described here, we have recently validated that 
MIR155 inhibits bone morphogenetic protein signaling by targeting several mediators including 
SMAD1 (relative expression [RNA-seq] of 0.27, FDR = 0) and SMAD5 (relative expression 
[RNA-seq] of 0.48, FDR = 0), which are known to activate transcription of MYO10 (relative 
expression [RNA-seq] of 0.3, FDR = 0) [Yin et al. 2010]. Quantitative PCR analysis of all three 
of these genes and Western blot analysis of SMAD1 and SMAD5 showed inhibition by MIR155 
in Mutu I cells [Yin et al. 2010]. The targeting of the MYO10 regulators, SMAD1 and SMAD5, 
in addition to the targeting of the MYO10 3’ UTR, illustrates a reinforcing mechanism that leads 
to greater suppression of MYO10 function. While we do not currently have similar regulatory 
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information on KLRA1 or HAL, they too are candidate genes that may be suppressed through 
direct and indirect mechanisms to enforce inhibition of cellular processes influenced by these 
genes. 
2.4 Materials and methods 
2.4.1 Biological experiments 
The sections related to cell culture, plasmid construction, generation of stable MIR 155 
expressing cell lines, RNA isolation and real-time RT-PCR analysis of MIR 155 levels can be 
found in the original paper [Xu et.al 2010].  And the details of western blot analysis and soft agar 
assay are discussed in section 2.4.15 and 2.4.16 in original paper [Xu et.al 2010]. 
2.4.2 Sequencing and base calling 
Preparation of transcription libraries for sequencing on the Illumina GA2x platform was 
carried out using the RNA-seq kit (Part no. 1004898 Rev. A) according to the manufacturer’s 
standard protocol. Briefly, purified RNA was fragmented via incubation for 5 min at 94°C with 
the Illumina-supplied fragmentation buffer. The first strand of cDNA was next synthesized by 
reverse transcription using random oligo primers. Second-strand synthesis was conducted by 
incubation with RNase H and DNA polymerase I. The resulting double-stranded DNA fragments 
were subsequently endrepaired, and A-nucleotide overhangs were added by incubation with Taq 
Klenow lacking exonuclease activity. After the attachment of anchor sequences, fragments were 
PCR-amplified using Illumina-supplied primers and loaded onto the GA2x flow cell. Image 
analysis and base calling were conducted with Firecrest and Bustard programs, respectively, and 
initial sequence alignment for QC purposes was performed with Eland.   
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2.4.3 Read mapping to genome and across splice sites  
Each short read file (sample), in the FASTQ format, was individually aligned against the 
Human Reference Genome (hg19) following a two-step procedure. The whole set of short reads 
was initially aligned to annotated exons using an exon aligner, Novoalign 
(http://www.novocraft.com). We used the following parameter settings to build novoindex and 
run Novoalign: 
1. Novoindex -k 14 -s 1 an index file name (e.g., hg37) reference genome files name (e.g., 
chr1.fa chr2.fa chr3.fa chr4.fa chr5.fa chr6.fa chr7.fa chr8.fa chr9.fa chr10.fa chr11.fa chr12.fa 
chr13.fa chr14.fa chr15.fa chr16.fa chr17.fa chr18.fa chr19.fa chr20.fa chr21.fa chr22.fa chrX.fa 
chrY.fa chrM.fa), where: -k 14 is the k-mer length to be used for the index; and -s 1 is the step 
size for the index. 
2. For searching the full human genome on a 16-GB RAM server, the recommended 
settings are k=14, s=1 or k =15, s =2. 
3. Novoalign -o SAM -f short read data file name (e.g., s_1_sequence.txt) -d file location 
(e.g., /Volumes/Macintosh HD 2/workspace/hg37) > s_1_novo_output, where -o SAM: the 
output file is in the SAM format; -f: the following file name is the input FASTQ file; and -d: 
directory where the output file should locate (note: users need to change it to the actual directory). 
4. Other options were set to the default. 
The Initially UnMapped reads are likely originated from exon–exon junctions that do not 
exist in the reference genome. IUMs were aligned to de novo assembled exon–exon junctions 
using the junction mapper, TopHat [Trapnell et al. 2009]. We used the following parameter 
settings to run TopHat:  
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1. TopHat -p 6 -G reference genome file name (e.g., output.gff.txt) bowtieindex file name 
(e.g., bowtieindex/hg37_bowtie) short read data file name (e.g., s_1_sequence.txt): -p: Uses 6 
threads to align reads; and -G: Supply TopHat with a list of gene model annotations in gff format 
(output.gff.txt). 
2. Other options were set to the default. 
2.4.4 Gene expression analysis using RNA-seq data 
We performed a genome-wide gene expression analysis using gene annotation 
downloaded from the UCSC Genome Browser. The expression abundance for gene i was 
quantified using the RPKM measure:               , where i is the gene index,    is the 
sum of short read counts mapped to exons and exon–exon junctions,    represents all mapped 
read counts in the lane, and    is the sum of exon lengths [Mortazavi et al. 2008].  
RPKM calculation was performed using an in-house-developed graphical user interface 
(GUI) software, SAMMate, which is freely available from http://sammate.sourceforge.net/. 
SAMMate takes the inputs of exon alignment files in .SAM format [Li et al. 2009], exon–exon 
junction alignment file in .BED format (optional), and genome annotation in a variety of formats 
to export a matrix of RPKM values for annotated genes. In addition, it also calculates RPKM 
values for each customized genomic interval. 
2.4.5 Analysis of Agilent MIR155 arrays 
Agilent microarray data for MIR155 transduced and control Mutu I samples were 
imported into the R software environment, version 2.7 (The R Development Core Team 2008), 
using the Bioconductor package ‘‘limma’’ [Gentleman et al. 2004; Smyth 2005]. Quality control 
was performed using limma functions and independently written R scripts. Within-array 
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normalization was performed using eCADS [Dabney and Storey 2007] to correct for gene-
specific dye bias. Normalized log-ratios were then analyzed using the one-class framework in 
SAM [Tusher et al. 2001] to identify probes differentially expressed with an estimated FDR of 0. 
2.4.6 Statistical treatment of sequencing and microarray data 
We performed differential expression analysis for the NGS data set (this study) and two 
previously published microarray data sets—mouse macrophage [O’Connell et al. 2008] and 
Human 293 cell line [Skalsky et al. 2007]. Differentially expressed genes were identified by 
significance analysis of microarrays (SAM) [Tusher et al. 2001]. SAM is a statistical technique 
in which significantly differentially expressed genes between control and miRNA-155 
transfected cell lines can be identified by assimilating a set of gene specific t-tests. Briefly, SAM 
computes a nonparametric score for each gene by dividing the between-group difference of 
(normalized log) gene expression levels and adjusted within-group gene expression variance 
across the whole genome. The score is then compared with random permutation scores that are 
computed in the same manner as the original score but based on randomly sampled gene 
expressions. The per-gene P-value was calculated by the percentage of scores that are larger than 
the original score in a fixed number of simulations, say, 1000. The per-gene P-values were 
further adjusted to the false discovery rate (FDR) [Storey and Tibshirani 2003], indicating the 
percentage of genes identified as being significant by chance alone. Here, we have used SAM’s 
two class analysis function to call significantly differentially expressed genes with an FDR of 0. 
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2.4.7 Cross-species gene mapping 
Cross-species gene mapping between human and mouse gene orthologs was done using 
the mapping file downloaded from 
http://www.informatics.jax.org/mgihome/projects/aboutmgi.shtml. 
2.4.8 Cross-platform comparison of targetome prediction using bitmap 
To systematically compare the technical capabilities of NGS and microarray platforms in 
detecting down-regulated genes, we used only gene identifiers that are common to all four 
platforms. Among these gene identifiers, we identified a down-regulated gene list with FDR = 0 
for each platform. Each of the genes was determined to be significantly down-regulated (at FDR 
= 0) or not in each of the four data sets; all genes were assigned to one of the    = 16 possible 
clusters, which is represented by color/white patterns and corresponding to 16 rows in the bitmap. 
The bitmap can be viewed as a generalized Venn Diagram to compare more than three groups. 
For example, the eighth row corresponds to 1859 (total) and 102 (8-mer seed containing) 
significantly downregulated genes identified at an FDR = 0 in NGS data. 
2.4.9 Statistical comparison of a pair of populations 
We used a rank-based two-sample one-sided Wilcoxon test to test the equality of two 
population means (  ) versus one is greater than another (  ). The R function wilcox.test() was 
used to perform this test. 
We used Levene’s test to test the equality of two population variances (  ) versus not 
equal (  ). The R function levene.test() was used to perform this test. We also used a 
Kolmogorov–Smirnov test to test the overall equality of two populations (  ) versus not equal 
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(  ). The R function ks.test() was used to perform this test. In all the above tests, small P-values 
(e.g., < 0.05) will reject the   . 
2.4.10 3’ UTR-luciferase reporter analysis 
For reporter analysis, 3.75  g of either the control (pMSCV-puro-GFP-miR-CNTL) or 
MIR155 (pMSCV-puro-GFP-MIR155) expression vector was cotransfected with 0.25  g of the 
appropriate pMIR-REPORT-dCMV or pGL4.11 3’ UTR reporter plasmid into       Mutu I 
cells using Lipofectamine 2000 (Invitrogen). Cells were harvested 48 h post-transfection and 
analyzed using the Promega firefly luciferase assay. The values reported are the expression 
change of a given 3’ UTR relative to change in the control reporter. 
2.4.11 Accession numbers 
Sequencing data will be available in the NCBI Short Read Archive, SRA011001. 
Microarray data submission to NCBI GEO database is in process. 
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2.5 Supplemental Figures 
 
Supplemental Figure 2.1. Lack of read evidence for MIR155 seed containing isoform of PCDH9.  
Schematic representation of PCDH9 locus with read and splicing evidence is shown in upper 
panel.  Transcription (TXN) proceeds leftward.  The reporter used for the 3’ UTR analysis 
contains the indicated 8-mer seed in the 3’ UTR from exon 5.  No reads were mapped to exons 3, 
4 or 5 but pileups are observed at exons 1 and 2 supporting expression of the third (short) 
isoform only. 
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Supplemental Figure 2.2. Read evidence for the last exon of MAP3K10 shows a sharp drop in 
mapped reads upstream from the MIR155 seed site.  The read dropoff corresponds to 
approximately the end of a transcript supported by Genbank evidence (Z48615). 
 
 
Supplemental Figure 2.3. Top biological functions implicated by Ingenuity Pathways 
Assessment (IPA) analysis of regulated genes.  Left panel shows the top 10 implicated biological 
functions identified and their associated p values from list of genes with MIR155 seeds with 
relative expression values of less than 0.6.  The right panel shows the top 10 implicated 
biological functions identified and their associated p values from list of genes with or without 
MIR155 seeds with relative expression values of less than 0.6 (     = -0.737) or greater than 1.7 
(    = 0.737).  Y axis shows        of p value.  The number of genes in the overlapping 
biological functions, cell cycle and cancer, are indicated. 
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Chapter 3. RNA-seq Analysis of EBV Transcriptome 
3.1 Background 
Microarrays have been used to assess the levels of EBV gene expression in experimental 
and clinical settings [Bernasconi et al. 2006; Li et al. 2006; Yuan et al. 2006; Zhang et al. 2006; 
Zheng et al. 2008].  Nevertheless, this analysis typically requires the use of custom arrays with 
user specified probes against each EBV gene of interest.  Despite their utility, microarrays have a 
limited dynamic range, being limited at the low end by the level of background and limited at the 
high end by signal saturation.  Further, the accuracy of microarray data can be a concern because 
of chip defects, cross hybridization, and the analog nature of the approach.  Accordingly, back-
to-back comparisons of microarray and RNA-seq data have demonstrated the enhanced 
performance of RNA-seq in the quantitative assessment of cellular transcripts [Marioni et al. 
2008; Mortazavi et al. 2009; Xu et al. 2010].  Using RNA-seq, transcript structure information 
can also be deduced from a relatively unbiased data set whereas transcript structure information 
derived from tiling microarrays is dependent on the probe design and is therefore subject to 
investigator biases. 
Due to the perceived potential of RNA-seq in transcriptome analysis, there has been 
intense interest in the development of informatics approaches to analyze cellular transcriptomes 
[Costa et al. 2010]. For the most part, these approaches should be directly applicable to the 
analysis of viral transcriptomes.  Nevertheless, the appropriately formatted annotation files for 
viruses or other ectopic organisms and the incorporation of this annotation information into 
existing pipelines have been lacking.  We have created the necessary annotation files for EBV 
and merged them with annotation files for the human cellular genome so that EBV specific 
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transcript data can be generated in the context of cellular data.  This pipeline allows for the 
simultaneous analysis of cellular and viral transcriptomes, the digital quantification of EBV 
transcripts, and the visualization of EBV specific reads and splice junctions on a genome 
browser (see supplemental file S1 for pipeline details).  Using this approach, we have analyzed 
EBV transcriptomes for the EBV-positive Burkitt’s lymphoma type I latency cell lines, Mutu I 
and Akata.   
3.2 Analysis of EBV gene expression in Mutu I and Akata cells 
 Sequencing data used for the Mutu I analysis were control samples from a previous study 
where we assessed miR-155 mediated cellular transcriptome changes [Xu et al. 2010] (available 
from the National Center for Biotechnology Information Sequence Read Archive (SRA011001)).  
For this study, two separate control RNA preps were generated and single-end 50 base technical 
replicates were run for each poly(A)+ selected RNA.  Akata sequencing data was generated 
anew from whole cell RNA prepared using a miRNeasy kit (Qiagen) according to the vendor’s 
protocol.  Akata sequencing libraries were generated using the Illumina RNA-seq kit (Part 
#1004898) and run on a GA2x machine for single-end 74 base extensions (deposition to National 
Center for Biotechnology Information Sequence Read Archive is in progress).  Sequences were 
simultaneously aligned to all human chromosomes plus the EBV genome (AG876 strain [Dolan 
et al. 2006], GenBank DQ279927) (see supplemental file S1 for general and detailed pipeline 
information). Reads per kilobase of exon per million mapped reads (RPKM – a measure of 
relative gene expression) values for all genes were calculated using SAMMate 
(http://sammate.sourceforge.net). 
Figure 3.1A shows the sequence read distribution across the entire EBV genome for 
Mutu I and Akata RNAs (an expanded/high resolution view can be seen in supplemental file S2).  
42 
 
Ample read evidence is observed across the majority of the EBV genome.  Despite this, however, 
the relatively few intergenic regions that exist within the EBV genome tend to lack reads (for 
example, see Figure 3.1B), supporting the contention that possible contaminating DNA does not 
represent a major source of read evidence.  The abundance of reads across all latency genes were 
relatively low and consistent with these cell lines exhibiting type I latency, no reads mapped to 
the EBNA2 open reading frame (Figure 3.1C and Figure 3.2).   
 
Figure 3.1. Visualization of RNA-seq coverage across the EBV genome.  Coverage (Wiggle) 
files generated from SAMMate and the EBV annotation file were loaded onto the Integrated 
Genome Viewer (IGV - developed at the Broad Institute (www.broadinstitute.org)).  The Y axis 
shows the number of reads mapping to each location of the genome.  Panel A shows the whole 
genome view, panel B shows a zoomed view of the intergenic region between the BMRF2 and 
BSLF2 genes, and panel C shows the lack of reads corresponding to the EBNA2 locus.  Data 
range for coverage data was set to 20 (for Mutu I) and 30 (for Akata) meaning that maximal 
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peaks represent genomic positions where there were at least 20 or 30 reads that crossed that 
genomic position. 
 
In contrast to the low levels of latency gene expression observed, we were surprised by 
the robust levels of many of the lytic genes in both Mutu I and Akata cells (Figures. 1 and 2).  
Many of these lytic genes show expression that is well above the median for all expressed 
cellular genes (median RPKM = 14.1 (Mutu I) and = 10.9 (Akata) - calculated as the median 
RPKM of genes with greater than 1 RPKM (1 RPKM typically represents approximately 1 
transcript per cell [Li et al. 2009]) (Figure 3.2A and B).  Strikingly, the BHLF1 and LF3 
transcripts are represented at such high levels that only between 0.66 to 2% of all annotated 
poly(A)+ cellular genes are expressed at higher levels in Mutu I and Akata cells (Figure 3.2C).  
The expression values observed here for EBV genes are not due to background since we ran 
RNA-seq data from the EBV negative cell lines, A549 [Reddy et al. 2009] and MCF7 [Wang et 
al. 2008] through our pipeline and obtained no alignments to the EBV genome (Figure 3.3).  The 
substantial average expression levels observed here for some lytic genes could arise from either 
their expression in latency and/or from very high expression in a small proportion of cells that 
are actively undergoing lytic replication.  The latter scenario most likely explains sequences 
obtained for most of these lytic genes.  Nevertheless, it is intriguing to speculate that the former 
scenario may account for at least some of these genes.  For example, BHLF1 and LF3 transcripts 
have been shown to be derived from multiple promoters, some of which are induced upon 
reactivation and others of which are constitutive [Gao et al. 1997; Xue et al. 2007].  The high 
transcript levels that we observed under non-induced conditions suggest that these genes may 
play a role in the latent phase of the EBV life cycle.  Overall, these data illustrate the sensitivity 
of RNA-seq for assessing transcript levels.  Further, the BHLF1 and LF3 examples described 
here illustrate how the digital nature of RNA-seq allows the user to compare the abundance of 
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transcripts from one gene with the abundance of transcripts of other genes within the 
transcriptome. 
 
Figure 3.2. RPKM values for EBV genes in Mutu I (A) and Akata (B) cells.  Mutu I results are 
the average of two technical replicates (TR) from each of two separate RNA preps.  Error bars 
indicate standard deviation for each gene. C) The number and percentage of genes showing 
higher RPKM values than BHLF1 and LF3 in Mutu I and Akata cells out of a total of 22,803 
annotated cellular and viral genes.   
 
Notably, despite carrying out poly(A)+ RNA selection prior to sequencing, we still detect 
the expression of non-polyadenylated transcripts such as the EBERs in Mutu I cells (Figure 3.2).  
However, we note that the error for non-polyadenylated transcripts tend to be high, probably due 
to differences in the efficacy of poly(A)+ RNA selection between the two biological replicates in 
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Mutu I cells.  Only low levels of EBERs were detected in Akata cells indicating that the 
poly(A)+ RNA selection was more effective in our newest RNA-seq experiment. 
 
Figure 3.3. Illustration of specificity for RNA-seq in assessing EBV transcriptomes.  The total 
number of reads that mapped to the EBV genome per 10 million mapped reads from the EBV 
positive cell lines, Akata and Mutu I, and the EBV negative cell lines, A549 and MCF7.  No 
EBV specific reads were identified in either of the EBV negative cell lines.  RNA1 and RNA2 
refer to biological replicate RNA samples from Mutu I cells.  TR1 and TR2 refer to technical 
sequencing replicates. 
3.3 Splicing evidence in Mutu I and Akata  
While RNA-seq can provide digital quantification of gene expression, reads that span 
exon junctions can provide information about gene isoform usage.  We used the junction mapper, 
Tophat [Trapnell et al. 2009], to identify junction mapped reads throughout the EBV genome 
(see supplemental file S1) for Mutu I and Akata.  While no evidence of Cp or Wp derived 
EBNA1 transcripts was found, evidence for Qp derived EBNA1 splice junctions was observed in 
both Mutu I and Akata cells (Figure 3.4A).  Junction reads were also detected for EBV lytic 
genes in both Mutu I and Akata cells including junction reads for both BZLF1 (Figure 3.4B) and 
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BSLF2/BMLF1 (supplemental file S3).  Further, evidence for multiple isoform expression (i.e. 
alternative splicing events) was detected for many genes such as BLLF1/BLLF2 (Figure 3.4C) as 
well as the complex BamHI A region [Edwards et al. 2008; Reddy et al. 2009]  (supplemental 
file S4).  Within the BamHI A region (supplemental file S4), for example, there is evidence for 
alternative splicing at the A73 gene in both Akata and in Mutu I with JUNC00000180 from Mutu 
I cells providing evidence of exon skipping (skipping of exons 2 and 3).  Within the genomic 
regions spanning the two BART microRNA clusters, there are very few reads, consistent with 
these microRNAs being produced from excised introns that are presumably unstable and non-
polyadenylated (and therefore not enriched during our poly(A)+ selection procedure).  In both 
Mutu I and Akata, there is evidence for two large introns that span the entire region of both of 
these clusters of microRNAs (JUNC00000094 and JUNC00000178 in Mutu I and 
JUNC00000053 and JUNC00000084 in Akata).  Consistent with this junction evidence, there are 
pronounced read spikes in Akata cells immediately upstream from the first junction (centered at 
position 139,270), between these two junctions (centered at position 147,770), and immediately 
downstream from the second junction (centered at position 151,115) (supplemental file S4) 
supporting the idea that a stable, poly(A)+ spliced transcript is generated from this transcription 
unit.  The two introns excised from this transcript can conceivably give rise to all BART 
microRNAs within these two clusters. 
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Figure 3.4. Visualization of junction evidence for EBNA1 (A), BZLF1 (B), and BLLF1/BLLF2 
(C).  Junction (BED) files were generated by the junction mapper, Tophat as outlined in 
supplemental file S1. 
3.4 Conclusions  
Our results show robust detection of EBV derived transcripts by RNA-seq using the 
pipeline outlined here (supplemental file S1).  From a quantitative standpoint, several studies 
have shown this approach to outperform microarrays since it is more accurate [Marioni et al. 
2008; Mortazavi et al. 2008; Xu et al. 2010] and since there is an inherently broad dynamic range.  
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For example, a previous report [Bernasconi et al. 2006] documented the difficulty in attaining 
confidence in detecting most EBV derived transcripts using microarrays because of low signal-
to-noise ratios.  Here, we show excellent coverage of the bulk of EBV genes (including lytic 
genes) in predominantly latently infected cell lines while at the same time detecting no EBV 
specific reads in two EBV-negative cell lines.  The digital nature of RNA-seq allows the user to 
better compare the relative expression of distinct genes through the calculation of RPKMs.  This 
allowed us to determine that BHLF1 and LF3 are among the most abundant genes expressed 
even in predominantly latently infected cell populations.  Lastly, RNA-seq inherently contains 
splice junction information that can be readily exploited to garner viral isoform expression 
patterns.  
Our approach can also be readily applied to other viruses by manual conversion of the 
respective annotation information (generally available at the National Center for Biotechnology 
Information database) to the appropriate format and its subsequent conjugation to cellular 
annotation files.  This should result in an improvement over microarrays in the analysis of virus-
associated transcriptomes not only for EBV but for other viruses.   
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Chapter 4. SAMMate GUI software system 
4.1 Introduction 
In chapter 2 and 3, we introduced transcriptome and targetome analysis using RNA-seq. 
A unique challenge for working with RNA-seq data is to extract useful information from short 
reads alignments stored in SAM/BAM format. Even though there are some software can process 
SAM/BAM file, most of them are not very convenient for researchers because they are using in 
command-line interface. In this section we introduce SAMMate which is a GUI software tool 
that allows biomedical researchers to easily access essential information stored in SAM/BAM 
files. A detailed documentation and a quick walkthrough are available at SAMMate's homepage 
[http://sammate.sourceforge.net]. SAMMate possesses the following key features (Figure 4.1): (1) 
For RNA-seq alignment SAMMate uses short reads originating from both exons and exon-exon 
junctions to calculate gene expression scores. SAMMate's versatility allows biomedical 
researchers to combine the output from an exon alignment program, such as Novoalign 
[http://www.novocraft.com/], with the output of a splice junction analysis program, such as 
Tophat [Trapnell et al. 2009]. This intuitive combination results in a more accurate estimation of 
gene expression abundance scores. (2). Using SAM/BAM files generated from short read 
alignments, SAMMate implements an efficient and fast algorithm to calculate a base-wise signal 
map. For large SAM/BAM files with more than          records, it only takes approximately 
one minute on a standard desktop or laptop computer to generate the base-wise signal map. (3). 
SAMMate also exports a wiggle file for visualization of alignment results on the UCSC genome 
browser. (4). Lastly, SAMMate exports an alignment statistics report. In addition, SAMMate has 
nice utilities for manipulating SAM/BAM files that include merging and sorting. We have 
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designed several case studies in the context of miRNA-155 target prediction to demonstrate the 
key features of SAMMate since these features are essential for solving a wide range of biological 
problems using NGS data. 
 
Figure 4.1. Key features of SAMMate: A schematic diagram of the four key features of 
SAMMate. (1) Fast calculation of gene expression RPKM scores combining exon reads and 
junction reads. (2) Fast calculation of whole-genome base-wise signal map. (3) Generation of 
wiggle files for short read alignment visualization. (4) Generation of an alignment statistics 
report. 
4.2 Key features 
4.2.1 Key feature: calculating genomic feature abundance scores 
Ideally, transcriptome characterization and quantification should be done on the isoform 
level. However, many existing approaches that quantify transcript abundance on the isoform 
level depend upon stringent assumptions such as a priori known isoform structures and suffer 
from identifiability problems. Moreover, the accuracy of these algorithms for high throughput 
studies is in doubt. It is also not known how sensitive these algorithms are to error-prone isoform 
annotation databases. Many existing approaches [Li et al. 2009; Jiang et al. 2009; Zheng et al. 
2009] have proved their merit as pilot studies. However, they were only validated using RT-PCR 
for a limited number of genes with simple and identifiable isoform transcript structures. With the 
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aforementioned in mind, transcript abundance quantification on the gene level remains one of the 
most demanded outputs from high throughput molecular profiling experiments such as 
microarray and NGS. The latter platform is much more sensitive in detecting low level gene 
expression and provides a much broader dynamic range of expression quantification. Taking 
gene expression profiling using Illumina Genome Analyzer as an example, Read Per Kilobase of 
exon model per million Mapped reads (RPKM) was used to score gene expression abundance. 
The values obtained can be interpreted as the number of copies of each transcript in the living 
cell where the average length of transcripts is 1KB [Mortazavi et al. 2008]. The RPKM scores 
can range from < 0.01 to > 10,000. There are now unprecedented and unparalleled opportunities 
to detect novel transcripts with ultra-low or ultra-high abundance. 
A unique challenge for researchers working with RNA-seq data are short reads 
originating from exon-exon junctions in cDNA (around 10%). These short reads fail to map back 
to the reference genome since the exons are separated by introns (Figure 4.2a). The millions of 
unmapped short reads originating from exon-exon junctions, denoted as Initially Unmapped 
Reads (IUM's), need to be accounted for when calculating RPKM scores [Trapnell et al. 2009]. 
Unfortunately, most alignment tools only map the short reads originating from exons completely 
ignoring IUMs in the process. Hereinafter, we denote such aligners as "exon aligner". To address 
the limitations of "exon aligners", ERANGE [Mortazavi et al. 2008], Tophat [Trapnell et al. 
2009] and rSeq [Jiang et al. 2008] are among the recently developed approaches to map IUM's 
originating from exon-exon junctions back to individual genes. ERANGE uses a union of known 
and novel junctions while Tophat de novo assembles IUM's using a module in Maq [Li et al. 
2008]. Hereinafter, we denote an aligner of this type as "junction mapper". Thus, there are now 
two types of aligners that complement each other. 
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Performance-wise, aligners vary vastly in accuracy as well as the underlying algorithms 
used. It is highly desirable for RNA-seq data analysis to allow users the freedom to choose and 
combine a pair of their favorite exon aligner and junction mapper to estimate gene expression 
scores. SAMMate fulfills this role by calculating and exporting a gene expression score matrix 
using a user-defined combination of an exon aligner and a junction mapper (Figure 4.2b). 
SAMMate then calculates the gene expression RPKM or FPKM score for gene i, R as    
 
      
    
  
   
; where i represents the gene index.   
  is the short read counts uniquely mapped to 
exons using an exon aligner (e.g. Novoalign), and   
  is the IUM short read counts uniquely 
mapped to the exon-exon junctions using a junction mapper (e.g. Tophat). N represents all 
uniquely mapped read counts in a cell extract sample, and    is the summation of the exon 
lengths. Thus, SAMMate combines short reads mapped to exons (e.g. available in SAM/BAM 
format) and to exon-exon junctions (e.g. available in BED format) to accurately estimate gene 
expression scores (Figure 4.2b). 
 
Figure 4.2. Combination of exon reads with junction reads to accurately calculate gene 
expression RPKM scores (a) A unique challenge for researchers working with RNA-seq data. 
The junction reads (red) fail to map back to the reference genome because exons are separated by 
introns. (b) A demonstration of the ideas of combing exon reads (black) and junction reads (red) 
to calculate gene expression RPKM scores. 
SAMMate can also take many pairs of SAM(BAM)/BED files simultaneously, one for 
each cell sample, to calculate a Microsoft EXCEL compatible gene expression matrix. In this 
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matrix rows correspond to genes or the customized genome coordinate intervals, and columns 
correspond to different cell samples. It must be noted that SAMMate is more flexible and 
accurate than other software, such as Tophat [Trapnell et al. 2009], that also export the gene 
expression scores. We validate our claim using experimental data obtained from 3' UTR assay as 
a case study shown below. SAMMate's reporting utility for gene expression abundance score is 
also quite versatile as this utility is not limited to the annotated genes. In fact, SAMMate 
calculates genomic feature abundance scores for any user-defined genomic intervals. This utility 
dramatically simplifies the technical barriers for discovering novel genes. 
4.2.2 Key feature: generating signal map for peak detection 
A signal map is a frequently demanded data format for NGS data analysis. In a signal 
map file, alignment results are represented in the per-base "pileup" format. In this format the 
single nucleotide short read coverage depth is calculated whereas the whole genome coverage is 
provided as a vector of integers with length        . A signal map is a common input for a 
number of frequently performed sequential analyses to detect a wide range of genomic features. 
For ChIP-seq and Methyl-seq data, significant peaks in a signal map may indicate potential 
transcription factor binding sites and DNA methylation sites, respectively. For DNA-seq data, 
significant change points in the signal map might indicate a true copy number change, which is 
often a hallmark of cancer [Chen et al. 2009]. 
4.2.3 Key feature: generating wiggle files for visualization 
Biomedical researchers also need to visualize the alignment results stored in SAM files in 
order to examine possible gene structure alterations between case and control studies. For 
example, shortened 3'-UTR's in cancer cells are reflected as an abrupt dropout of the short read 
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coverage. This visualization need is addressed by another key feature of SAMMate. SAMMate 
can take the alignment results stored in SAM files and export the genome information to wiggle 
(.wig) files where the wiggle format is compatible with the UCSC genome browser and other 
browsers used for visualization. This feature will allow biomedical researchers to visually check 
the alignment quality of selected genes in selected genomic regions. For the miRNA-155 target 
prediction research, Figure 4.3 presents two typical scenarios: the left and right panels show the 
alignment results in the pile-up format for gene CXorf39 on Chromsome X and gene LBA1 on 
Chromsome 3, respectively. Figure 4.3a indicates no overall expression change in the codon 
regions, but a significant dropout in the 3'-UTR region occurs. On the contrary, Figure 4.3b 
shows no significant difference in the 3'-UTR region but a significant difference in the codon 
region instead. These two examples demonstrate SAMMate's ability to generate wiggle files for 
biomedical researchers allowing them to visually look for possible gene structure alterations. 
While there are a number of existing alignment visualization software (e.g. [Bao et al. 2009; 
Arner et al. 2010]), these systems do not allow many annotation tracks in parallel, which is the 
deterministic feature for knowledge discovery. 
 
Figure 4.3. Visualization of gene structure sariation. Two typical examples were shown: (1) 
Gene CXorf39 was called by the Change Point Analysis as a potential miRNA-155 target due to 
it's abrupt read dropout on the 3'-UTR end. (2) Gene LBA1 was called by the Differential 
Expression Analysis as a potential miRNA-155 target due to the overall read coverage decrease 
in codon region. 
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4.2.4 Key feature: generating alignment report 
Short read alignment statistics provide indispensable resources to examine the alignment 
quality as well as comparing alignment results. SAMMate calculates and exports a number of 
alignment statistics including the percentage of uniquely mapped short reads and the percentage 
of short reads mapped to intergenic, exonic and intronic regions. 
4.3 Conclusion 
We have implemented a GUI software to allow biomedical researchers to parse, process 
and integrate alignment information stored in SAM/BAM files. With this tool biomedical 
researchers are able to calculate gene expression abundance using either standard or customized 
annotations. They are also able to visualize and compare alignment results with great ease. These 
utilities and their biological impact are adequately demonstrated via the case studies of miRNA 
target prediction. The biological applications of SAMMate, however, are not limited to miRNA 
target prediction alone. In fact, SAMMate applies to any biological problem whose solution 
depends on the gene expression abundance score and base-wise short read coverage signal. 
SAMMate is also highly modular and extensible providing a programmer friendly interface for 
ease of updates and the incorporation of contributions from the community. Our tool will greatly 
facilitate the downstream analysis of genomic sequencing data. 
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Chapter 5. Conclusion and Future Works 
5.1 Conclusion 
We provided a GUI software pipeline to analyze transcriptome changes induced by the 
human microRNA MIR155 using RNA-seq. A comparison with 3’ UTR reporter assay 
demonstrated general concordance between NGS and corresponding 3’ UTR reporter results. 
Nonharmonious results were investigated more deeply using transcript structure information 
assembled from the NGS data. This analysis revealed that transcript structure plays a substantial 
role in mitigated targeting and in frank targeting failures.  
In analysis of EBV transcriptome, our results also showed robust detection of EBV 
derived transcripts by RNA-seq using the pipeline outlined here. From a quantitative standpoint, 
several studies have shown this approach to outperform microarrays since it is more accurate 
[Marioni et al. 2008; Mortazavi et al. 2008; Xu et al. 2010] and since there is an inherently broad 
dynamic range. The digital nature of RNA-seq allows users to better compare the relative 
expression of distinct genes through the calculation of RPKMs. This should result in an 
improvement over microarrays in the analysis of virus-associated transcriptomes not only for 
EBV but for other viruses. With its high level of accuracy, its broad dynamic range, its utility in 
assessing transcript structure, and its capacity to accurately interrogate global direct and indirect 
transcriptome changes, NGS is a useful tool for investigating the biology and mechanisms of 
action of microRNAs.  
For efficiently processing NGS data, our GUI software SAMMate allows biomedical 
researchers to quickly process SAM/BAM files and is compatible with both single-end and 
paired-end sequencing technologies. SAMMate also automates some standard procedures in 
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DNA-seq and RNA-seq data analysis. Using either standard or customized annotation files, 
SAMMate allows users to accurately calculate the short read coverage of genomic intervals. In 
particular, for RNA-seq data SAMMate can accurately calculate the gene expression abundance 
scores for customized genomic intervals using short reads originating from both exons and exon-
exon junctions. Furthermore, SAMMate can calculate a whole-genome signal map at base-wise 
resolution in a short time allowing researchers to solve an array of bioinformatics problems. 
Finally, SAMMate can export both a wiggle files for alignment visualization in the UCSC 
genome browser and an alignment statistics report. The biological impact of these features has 
been already demonstrated via several case studies that predict miRNA targets using short read 
alignment information files. 
With just a few mouse clicks, SAMMate will provide biomedical researchers easy access 
to important alignment information stored in SAM/BAM files. Our software is constantly 
updated and will greatly facilitate the downstream analysis of NGS data. Both the source code 
and the GUI executable are freely available under the GNU General Public License at 
http://sammate.sourceforge.net. 
5.2 Future works 
Genome-wide analysis of transcriptomes at the isoform level is our ultimate goal in the 
future research work. Alternative splicing is one of the key gene expression regulation 
mechanisms at the transcription level, giving rise to transcriptome diversity. It is estimated that 
as many as 90% human genes are alternatively spliced in different tissues and conditions, and 
point mutations in splice sites are responsible for at least 15% of all disease-causing mutations. 
The problem itself is challenging due to the fact that the observed exonic expression signal can 
be aggregated from a set of sibling isoforms encoded by the same gene with diverse alternative 
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splicing mechanisms. In essence, the problem finds its root in latent variable models where we 
infer the latent variables (isoform expression) from the observed variables (exonic expression). 
However, the development of computational algorithms to deconvolve the gene expression 
signal emitted from each splicing isoform is not a trivial task.  
Therefore, my future research work for transcriptome quantification is to estimate 
isoform abundance using base-wise RNA-seq data and then integrate the algorithm into 
SAMMate. We will finally develop a GUI software pipeline for quantifying human 
transcriptome (whole set of mRNA transcripts) using the NGS data.  
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